Woman, 21, whose painful mouth ulcers were dismissed as ‘tonsillitis’
Melanoma patient outcomes predicted by computational biology
Walter and Eliza Hall Institute researchers have used computational biology
Intelligent testing could save lives by defusing ticking time bomb of liver disease
A new way of detecting liver disease decades before it
Novel agent reactivates an immune call by LIF blockade
Results from a study spearhead by researchers at the Vall
Irregular sleep raises risks of obesity and hypertension by 27%
Sleeping odd, inconsistent hours raises your risks of obesity and
Tracking the epigenetic evolution of a cancer, cell by cell
A powerful new set of scientific tools developed by Weill
Global study predicts more than 50 percent rise in chemotherapy demand by 2040
To deliver optimal treatment by 2040, a significant expansion of
New target for chronic pain relief confirmed by scientists
A research group at Hiroshima University observed a potential new
Polymer valves refined by computer simulations aim to reduce costs, improve minimally-invasive procedures
NIBIB-funded engineers are designing and testing aortic heart valve replacements
CymaBay Therapeutics Announces Seladelpar Granted Breakthrough Therapy Designation by the FDA for the Treatment of Primary Biliary Cholangitis
NEWARK, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) — CymaBay Therapeutics,